Check-Cap Ltd Ord (CHEK)

$0.81 +0.01 (1.25%)
Market Cap 4.68M
Revenue (ttm) 0.00
Net Income (ttm) -17.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 5,800
Avg Vol 201,492
Day's Range N/A - N/A
Shares Out 5.85M
Stochastic %K 25%
Beta 0.20
Analysts Strong Buy
Price Target $7.00

Latest News on CHEK

Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Mar 25, 2024, 7:15 PM EDT - 1 year ago

Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

Dec 22, 2023, 10:36 AM EST - 1 year ago

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

Dec 13, 2023, 12:37 PM EST - 1 year ago

CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

Dec 8, 2023, 11:18 AM EST - 1 year ago

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

Dec 5, 2023, 3:42 PM EST - 1 year ago

CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting

Nov 28, 2023, 11:56 AM EST - 1 year ago

Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting

Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Nov 28, 2023, 11:42 AM EST - 1 year ago

Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Nov 27, 2023, 8:00 AM EST - 1 year ago

Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Aug 16, 2023, 5:08 PM EDT - 1 year ago

Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Check-Cap Reports Second Quarter 2023 Financial Results

Aug 4, 2023, 4:15 PM EDT - 1 year ago

Check-Cap Reports Second Quarter 2023 Financial Results

SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE

Jul 25, 2023, 10:22 AM EDT - 1 year ago

SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE

Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce

Jun 6, 2023, 7:00 AM EDT - 1 year ago

Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce

Check-Cap Reports First Quarter 2023 Financial Results

May 11, 2023, 4:30 PM EDT - 2 years ago

Check-Cap Reports First Quarter 2023 Financial Results

Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 31, 2023, 4:45 PM EDT - 2 years ago

Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results

Check-Cap Issues an Update to Shareholders

Mar 21, 2023, 9:00 AM EDT - 2 years ago

Check-Cap Issues an Update to Shareholders

Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

Nov 30, 2022, 8:30 AM EST - 2 years ago

Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Aug 31, 2022, 8:00 AM EDT - 2 years ago

Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

Jun 23, 2022, 8:30 AM EDT - 3 years ago

Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update

Jun 1, 2022, 8:00 AM EDT - 3 years ago

Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update

Check-Cap Announces Initiation of the U.S. Pivotal Trial

May 11, 2022, 8:00 AM EDT - 3 years ago

Check-Cap Announces Initiation of the U.S. Pivotal Trial

Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results

Apr 7, 2022, 8:30 AM EDT - 3 years ago

Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results

Check-Cap Ltd. Announces $10 Million Registered Direct Offering

Mar 1, 2022, 8:30 AM EST - 3 years ago

Check-Cap Ltd. Announces $10 Million Registered Direct Offering

FDA Gives Green To Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Test

Feb 7, 2022, 10:19 AM EST - 3 years ago

FDA Gives Green To Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Test

Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

Feb 7, 2022, 8:30 AM EST - 3 years ago

Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

Check-Cap Issues Letter to Shareholders

Jan 5, 2022, 9:15 AM EST - 3 years ago

Check-Cap Issues Letter to Shareholders

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

Dec 23, 2021, 4:15 PM EST - 3 years ago

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®

Nov 22, 2021, 8:00 AM EST - 3 years ago

Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®

Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update

Nov 3, 2021, 8:30 AM EDT - 3 years ago

Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update

Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories

Nov 2, 2021, 8:30 AM EDT - 3 years ago

Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories

Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

Oct 18, 2021, 8:00 AM EDT - 3 years ago

Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs

Sep 1, 2021, 8:30 AM EDT - 3 years ago

Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs

Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update

Aug 5, 2021, 8:30 AM EDT - 3 years ago

Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update

Check-Cap Ltd. Announces $35 Million Registered Direct Offering

Jun 30, 2021, 8:12 AM EDT - 4 years ago

Check-Cap Ltd. Announces $35 Million Registered Direct Offering

Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update

May 12, 2021, 8:00 AM EDT - 4 years ago

Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update

Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results

Mar 19, 2021, 7:00 AM EDT - 4 years ago

Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results

FDA Signs Off Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Technology

Mar 15, 2021, 7:34 AM EDT - 4 years ago

FDA Signs Off Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Technology

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

Mar 15, 2021, 7:00 AM EDT - 4 years ago

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

Check-Cap: Come Back In A Year

Jan 28, 2021, 10:44 AM EST - 4 years ago

Check-Cap: Come Back In A Year

Check-Cap Announces Exercise of Warrants For $9.6 Million Gross Proceeds

Jul 23, 2020, 9:35 AM EDT - 5 years ago

Check-Cap Announces Exercise of Warrants For $9.6 Million Gross Proceeds

Check-Cap Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 27, 2020, 4:45 PM EDT - 5 years ago

Check-Cap Reports First Quarter 2020 Financial Results and Provides Corporate Update

Check-Cap Announces Final Results From Post-CE Approval Study Of C-Scan

Jul 9, 2019, 7:58 AM EDT - 6 years ago

Check-Cap Announces Final Results From Post-CE Approval Study Of C-Scan